We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.71B
1-Year Est. Return
65.19%
This Fund
S&P 500
This Quarter
Est. Return
+14.4%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.25B
AUM Growth
+$91M
(+2.9%)
Cap. Flow
-$180M
Cap. Flow
% of AUM
-5.53%
Top 10 Holdings %
Top 10 Hldgs %
17.1%
Holding
462
New
59
Increased
82
Reduced
124
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$36.3M |
| 2 |
Union Pacific
UNP
|
+$36.1M |
| 3 |
PVH
PVH
|
+$31.6M |
| 4 |
ServiceNow
NOW
|
+$26.6M |
| 5 |
Apple
AAPL
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$37.7M |
| 2 |
Citigroup
C
|
+$36.3M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$28.5M |
| 4 |
Monster Beverage
MNST
|
+$28.2M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.98% |
| 2 | Technology | 17.39% |
| 3 | Consumer Discretionary | 13.79% |
| 4 | Financials | 12.58% |
| 5 | Industrials | 12.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEWR
126
DELISTED
New Relic, Inc.
NEWR
| $8.38M | 0.26% |
83,265
-3,106
| -4% | -$276K |
|
127
MPLX
MPLX
$59.2B
| $8.33M | 0.26% |
243,998
-62,530
| -20% | -$2.18M |
|
128
Plains All American Pipeline
PAA
$18.2B
| $8.29M | 0.26% |
350,790
-25,540
| -7% | -$615K |
|
129
Agios Pharmaceuticals
AGIO
$1.96B
| $8.11M | 0.25% |
+96,330
| New | +$8.4M |
|
130
Burlington
BURL
$14.3B
| $8.07M | 0.25% |
53,620
+49,180
| +1,108% | +$7M |
|
|
WCG
131
DELISTED
Wellcare Health Plans, Inc.
WCG
| $8.05M | 0.25% |
+32,680
| New | +$7.12M |
|
|
AAN.A
132
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $8M | 0.25% |
184,115
-96,900
| -34% | -$4.21M |
|
133
CDW
CDW
$19.2B
| $7.89M | 0.24% |
+97,705
| New | +$7.56M |
|
134
Heron Therapeutics
HRTX
$59.6M
| $7.81M | 0.24% |
201,080
+141,505
| +238% | +$4.5M |
|
135
Radware
RDWR
$1.25B
| $7.75M | 0.24% |
306,467
-436
| -0.1% | -$10.1K |
|
|
MLNX
136
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $7.69M | 0.24% |
91,195
+17,295
| +23% | +$1.42M |
|
137
Jazz Pharmaceuticals
JAZZ
$15.6B
| $7.55M | 0.23% |
43,795
+10,595
| +32% | +$1.73M |
|
138
Gilead Sciences
GILD
$181B
| $7.54M | 0.23% |
106,508
-1,240
| -1% | -$87.6K |
|
139
VF Corp
VFC
$5B
| $7.49M | 0.23% |
97,625
-307,118
| -76% | -$23.1M |
|
|
SPLK
140
DELISTED
Splunk Inc
SPLK
| $7.48M | 0.23% |
75,429
-230,988
| -75% | -$25.1M |
|
|
LPSN
141
DELISTED
LivePerson
LPSN
| $7.44M | 0.23% |
23,500
-7,768
| -25% | -$2.2M |
|
142
Associated Banc-Corp
ASB
$5.73B
| $7.39M | 0.23% |
+270,810
| New | +$7.26M |
|
|
GLUU
143
DELISTED
Glu Mobile Inc.
GLUU
| $7.34M | 0.23% |
1,144,492
-56,130
| -5% | -$292K |
|
|
MMP
144
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $7.25M | 0.22% |
104,912
| – | – |
|
145
GoDaddy
GDDY
$13B
| $7.21M | 0.22% |
102,060
-8,415
| -8% | -$572K |
|
|
WPZ
146
DELISTED
Williams Partners L.P.
WPZ
| $7.2M | 0.22% |
177,410
+57,800
| +48% | +$2.2M |
|
147
Halozyme
HALO
$12.1B
| $7.14M | 0.22% |
423,305
-9,579
| -2% | -$181K |
|
|
ADSW
148
DELISTED
Advanced Disposal Services Inc
ADSW
| $7.13M | 0.22% |
+287,670
| New | +$6.68M |
|
|
AVTA
149
DELISTED
Avantax, Inc. Common Stock
AVTA
| $7.08M | 0.22% |
+191,345
| New | +$6.17M |
|
|
CURO
150
DELISTED
CURO Group Holdings Corp.
CURO
| $7.06M | 0.22% |
+282,964
| New | +$6.21M |
|
Similar funds
MSC
BC
FEG
HCM
OH
BCM
CCI
MCM
Castleark Management's Q2 2018 Portfolio in Review
As of Q2 2018, Castleark Management held 462 positions worth $3.25B, up 2.9% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Castleark Management withdrew a net $180M in Q2 2018, closing 93 positions and reducing 124 holdings. Its most notable exit was Monster Beverage, an estimated $28.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in Union Pacific worth $36.7M.
- Castleark Management's largest Q2 2018 buy was Union Pacific: 258,850 shares worth $36.7M.
- Castleark Management added most to Costco in Q2 2018, an estimated $36.3M increase.
- Castleark Management's biggest Q2 2018 reduction was Abiomed Inc, cutting an estimated $37.7M.
- Castleark Management fully exited Monster Beverage in Q2 2018, selling an estimated $28.2M.
- Castleark Management's ten largest holdings make up 17% of its $3.25B portfolio in Q2 2018.
- Castleark Management opened 59 new positions and closed 93 in Q2 2018.
- Castleark Management's portfolio value rose 2.9% quarter-over-quarter to $3.25B.
Based on Castleark Management's 13F filing for Q2 2018, filed 15 Aug 2018.